NDC 63539-024

Lyrica CR

Pregabalin

Lyrica CR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Pregabalin.

Product ID63539-024_9e25a642-501e-4139-bded-aff0ded0ebf9
NDC63539-024
Product TypeHuman Prescription Drug
Proprietary NameLyrica CR
Generic NamePregabalin
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2016-01-01
Marketing CategoryNDA / NDA
Application NumberNDA209501
Labeler NameU.S. Pharmaceuticals
Substance NamePREGABALIN
Active Ingredient Strength165 mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63539-024-02

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63539-024-02)
Marketing Start Date2016-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63539-024-02 [63539002402]

Lyrica CR TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA209501
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-01

Drug Details

Active Ingredients

IngredientStrength
PREGABALIN165 mg/1

OpenFDA Data

SPL SET ID:847e8b4e-4c14-4c36-b824-5e1ab6a5db6f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1988974
  • 1994389
  • NDC Crossover Matching brand name "Lyrica CR" or generic name "Pregabalin"

    NDCBrand NameGeneric Name
    0071-1026Lyrica CRLyrica CR
    0071-1027Lyrica CRLyrica CR
    0071-1029Lyrica CRLyrica CR
    63539-024Lyrica CRLyrica CR
    0071-1012LyricaPREGABALIN
    0071-1013LyricaPREGABALIN
    0071-1014LyricaPREGABALIN
    0071-1015LyricaPREGABALIN
    0071-1016LyricaPREGABALIN
    0071-1017LyricaPREGABALIN
    0071-1018LyricaPREGABALIN
    0071-1019LyricaPREGABALIN
    0071-1020LyricaPREGABALIN

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.